Product
Insulin Glargine - Insulin Aspart
1 clinical trial
2 indications
Indication
Diabetes MellitusIndication
Type 2 diabetesClinical trial
Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 AnalogueStatus: Recruiting, Estimated PCD: 2023-08-30